HKU Scholars Hub: Browsing DSpace

Browsing by Author Sriuranpong, V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 9 of 9

	Title	Author(s)	Issue Date	Views
	A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma Journal:Therapeutic Advances in Medical Oncology	Qin, S Chan, SL Sukeepaisarnjaroen, W Han, G Choo, SP Sriuranpong, V Pan, H Yau, T Guo, Y Chen, M Ren, Z Xu, J Yen, CJ Lin, ZZ Manenti, L Gu, Y Sun, Y Tiedt, R Hao, L Song, W Tanwandee, T	2019	80
	Adaptation Of International Guidelines For Metastatic Colorectal Cancer: An Asian Consensus Journal:Clinical Colorectal Cancer	Cheng, AL Li, J Vaid, AK Ma, B Teh, CS Ahn, JB Bello, M Charoentum, C Chen, LT de Lima Lopes Jr, G Ho, GF Kong, HL Lam, KO Liu, TS Park, YS Sriuranpong, V Sudoyo, AW Wang, JY Zhang, J Zhang, SZ Ciardiello, F Kohne, CH Shaw, M Kim, TW	2014	71
	Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study Proceeding/Conference:European Society for Medical Oncology (ESMO) Asia Congress, 2017	Mok, T Peter, S Camidge, DR Ou, SH Ahn, JS Tan, EH Li, Z Lee, JS Cho, BC Geater, S Sriuranpong, V Ho, JCM Chan, SH Zeiter, A Balas, B Nueesch, E Mitry, E Morcos, PN Kim, DW	2017	46
	Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines Journal:Oral Oncology	D'cruz, A Lin, T Anand, AK Atmakusuma, D Calaguas, MJ Chitapanarux, I Cho, BC Goh, BC Guo, Y Hsieh, WS Hu, C Kwong, DLW Lin, JC Lou, PJ Lu, T Prabhash, K Sriuranpong, V Tang, P Vu, VV Wahid, I Ang, KK Chan, AT	2013	82
	Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations Journal:International Journal of Clinical Oncology	Chang, GC Lam, DCL Tsai, CM Chen, YM Shih, JY Aggarwal, S Wang, S Kim, SW Kim, YC Wahid, I Li, R Lim, DWT Sriuranpong, V Chan, RTT Lorence, RM Carriere, P Raabe, C Cseh, A Park, K	2021	26
	Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-lung cancer (FASTACT-2): a randomised, double-blind trial Journal:Lancet Oncology	Wu, YL Lee, JS Thongprasert, S Yu, CJ Zhang, L Ladrera, G Srimuninnimit, V Sriuranpong, V Sandoval-Tan, J Zhu, Y Liao, M Zhou, C Pan, H Lee, VHF Chen, YM Sun, Y Margono, B Fuerte, F Chang, GC Seetalarom, K Wang, J Cheng, CK Syahruddin, E Qian, X Ho, JCM Kurnianda, J Liu, HE Jin, K Truman, M Bara, I Mok, T	2013	64
	Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology	Lu, S Mok, T Lu, Y Zhou, Y Shi, YK Sriuranpong, V Ho, JCM Ong, CK Tsai, CM Chung, CH Wilner, KD Tang, Y Masters, E Selaru, P Wu, YL	2016	174
	A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology	Mok, T Wu, YL Thongprasert, S Yu, CJ Zhang, L Ladrera, GE Srimuninnimit, V Sriuranpong, V Sandoval-Tan, J Zhu, Y Liao, M Zhou, C Pan, H Lee, V Chen, YM Sun, Y Margono, B Jin, K Truman, M Lee, JS	2012	93
	Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer Journal:Journal of Thoracic Oncology	Wu, YL Lu, S Lu, Y Zhou, JY Shui, YK Sriuranpong, V Ho, JCM Ong, CK Tsai, CM Chung, CH Wilner, KD Tang, Y Masters, ET Selaru, P Mok, TS	2018	60

Showing results 1 to 9 of 9